Sign in
8-K

Current Report

Larimar Therapeutics, Inc. Filed Acc 0001193125-18-201664

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d466524d8k.htm…